Form 4 for SPRO Spero Therapeutics, Inc.
Accepted 2026-08-06 18:49:22 ET · period of report 2026-08-03 · accession 0001807743-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-06 18:49 | 2026-08-03 | SPRO | Zack Debra | Chief Medical Off | A - Grant | $0.00 | +162.3K | 162.3K | New | $0 |
| DT | 2026-08-06 18:49 | 2026-08-03 | SPRO | Zack Debra | Chief Medical Off | A - Grant | $0.00 | +324.7K | 324.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | A | A | 162,311 | $0.00 | 162,311 | D | — | — | (F1) Consists of restricted stock units ("RSUs") granted to Reporting Person under Issuer's 2019 Stock Incentive Plan. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 3, 2027, subject to the Reporting Person's continued service through the applicable vesting date. |
| 2 | Derivative | Stock option (right to buy) | 2026-08-03 | A | A | 324,675 | $0.00 | 324,675 | D | $1.54 · — to 2036-08-03 | 324,675 Common Stock | (F2) The shares underlying this option vest as to 25% on August 3, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |